国内成人精品一区二区,男人天堂国产精品,国产精品一级二区三区,一卡2卡3卡4卡无卡免费网站,黄色视频在线观看播放,欧美在线观看免费资源,奇米影视7777w久久精品,韩国精品视频黄色网站

Recombinant COVID-19 Vaccine (Sf9 cell)
2025-07-03
[NAME OF THE MEDICINAL PRODUCT] Recombinant COVID-19 Vaccine (Sf9 cell)
[ADJUVANT] Aluminum hydroxide
[THERAPEUTIC INDICATION] The product is indicated for active immunization to prevent coronavirus (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

[STRENGTHS] Each vial contains 1.0 mL. Single dose of 1.0 mL contains 40 μg of recombinant SARS-CoV-2 S-RBD protein.

On December 2, 2022, it was approved by the relevant national authorities for emergency use.


Recombinant COVID-19 Vaccine (Sf9 cell) Package Insert